Sinopharm Group Co. Ltd. (X2S1)
Market Open
15 Oct, 06:12 AM
XFRA 
OTC PINK Primary XFRA €
8. 75
+0.25
+2.9412%
€
6.8B Market Cap
6.6 P/E Ratio
6.89% Div Yield
80 Volume
0 Eps
€ 8.5
Previous Close Want to track X2S1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinopharm Group Co. Ltd. (X2S1) Statistics
Valuation metrics
Market Cap 6.8B
Enterprise value 13.28B
Trailing P/E (ttm) 7.62
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.01
Price/Book (mrq) 0.65
Enterprise Value/Revenue 0.19
Enterprise Value/EBITDA 5.47
Overview
Shares outstanding 3.12B
Float 1.34B
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 12
Average volume (90 days) 9
Price summary
52-Week low 8.05
52-Week high 11.8
Beta 0.6
50-Day moving average 11.37
200-Day moving average 10.81
Dividends and splits
Forward annual dividend rate 1.6
Forward annual dividend yield 0.1471%
Trailing annual dividend rate 0.4
Trailing annual dividend yield 0.0368%
5-Year annual dividend yield -
Payout ratio 0.29
Dividend Date 8 Sep 2026
Ex-Dividend Date 24 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin 0.01%
Operating margin 0.04%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.08%
Income Statement
Revenue (ttm) 71.59B
Revenue per share (ttm) 921.59
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 5.19B
EBITDA 24.14B
Net income to common (ttm) 890.52M
Diluted EPS (ttm) 1.43
Quarterly earnings growth (yoy) 0.04%
Balance Sheet
Total cash (mrq) 6.07B
Total cash per share (mrq) 15.64
Total debt (mrq) 8.83B
Total Debt/Equity (mrq) 52.89
Current ratio (mrq) 1.41%
Book value per share (mrq) 16.74
Cash Flow
Cash flow statement 1.76B
Levered free cash flow (LFCF) -38.7M
2026 © Marketlog. All Rights Reserved.
